Baugh & Associates’s ASML ASML Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.84M Buy
2,899
+154
+6% +$267K 2.19% 24
2026
Q2
$5.46M Sell
2,745
-254
-8% -$404K 2.42% 18
2026
Q1
$3.96M Sell
2,999
-3
-0.1% -$4.11K 1.71% 29
2025
Q4
$2.96M Sell
3,002
-55
-2% -$57.4K 1.46% 30
2025
Q3
$2.74M Sell
3,057
-9
-0.3% -$7.08K 1.36% 29
2025
Q2
$2.28M Sell
3,066
-52
-2% -$37.3K 1.19% 29
2025
Q1
$1.95M Buy
+3,118
New +$2.27M 0.99% 30

Other funds holding ASML

Baugh & Associates's ASML Position: Q3 2026 in Review

Baugh & Associates increased its ASML (ASML) stake by 5.6% in Q3 2026, buying an estimated $267K and bringing the position to 2,899 shares worth $4.84M. The position accounts for 2.19% of the portfolio, ranked #24.

Baugh & Associates first reported a position in ASML in Q1 2025 and has held it in 7 quarters since. The position peaked at $5.46M in Q2 2026. 1,109 funds tracked by Wall St. Rank hold ASML as of Q3 2026.

  • Baugh & Associates held 2,899 shares of ASML worth $4.84M as of Q3 2026.
  • Baugh & Associates bought 154 ASML shares in Q3 2026, an estimated $267K.
  • ASML made up 2.19% of Baugh & Associates's portfolio in Q3 2026, its #24 holding.
  • Baugh & Associates first reported a position in ASML in Q1 2025 and has held it in 7 quarters since.
  • Baugh & Associates's ASML position peaked at $5.46M in Q2 2026.
  • 1,109 funds tracked by Wall St. Rank held ASML as of Q3 2026.

Based on Baugh & Associates's 13F filing for Q3 2026, filed 16 Oct 2026.